Gordon Gary B. 4
4 · Ayala Pharmaceuticals, Inc. · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Gordon Gary B.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$5.16/sh+3,000$15,480→ 11,520 total - Sale
Common Stock
2021-02-24$17.46/sh−3,000$52,385→ 8,520 total - Exercise/Conversion
Stock Option
2021-02-24−3,000→ 89,000 totalExercise: $5.16Exp: 2029-09-19→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This option vested and became exercisable as to 25% of the underlying shares of common stock on August 1, 2020 and will become vested and exercisable as to the remainder of the shares in 12 equal quarterly installments thereafter.